Neuro Advance
Date: Location: Cost:
October 11, 2017 Harvard Medical School - Joseph B. Martin Conference Center
77 Avenue Louis Pasteur
Boston, MA 02115

Starting at $1950

 

Dress Code:
Business Attire

Register

NEURO ADVANCE - October 11, 2017 - DRAFT

Co-hosts: Adam Bruce, Elliot Ehrich, Ole Isacson, Gerhard Koenig, Jonathan Lewis, Michael Davidson, Ivana Magovcevic-Liebisch, Klaus Mendla, Ken Rhodes, Cynthia Schwalm, Alex Tkachenko

Time Agenda
7:00-8:00 am

Registration and Networking Breakfast

8:00-8:30 am

Welcome and Opening Remarks
Adam BruceFounder, TikoMed

8:30-9:00 am

Challenges of CNS Translational Research
Samantha Budd Haeberlein, VP, Alzheimer's Disease Clinical Development, Biogen: Maria MaccecchiniPresident & CEO, QR Pharma; Deborah RathjenCEO & Managing Director, Bionomics; Darryle SchoeppVP & Head, Neuroscience, Merck

Darryle SchoeppVP & Head, Neuroscience, MerckDarryle SchoeppVP & Head, Neuroscience, Merck
9:00-9:30 am

Financing Innovation in Neuroscience
Adam BruceCEO & Founder, TikoMed; Ivana Magovcevic-Liebisch, EVP, Axcella Health; Bob Silverman, Head, Externalized Drug Discovery Partnering, Roche; Erika SmithCEO, ReNetX Bio; Amir TamizDirector, Division of Translational Research, NIH

9:30-10:00 am

Novel Approaches to Alzheimer’s Disease
Larry Altstiel, CMO, vTv Therapeutics; Roger Bullock, CMO, Oryzon; John Hoekman, CEO, Impel Neuropharma; Leen KawasPresident & CEO, M3 Biotechnology; Kenneth Moch, President & CEO, Cognition Therapeutics
Moderator: Jonathan LewisCEO, Samus Therapeutics

10:00-10:30 am

Networking Break

10:30-11:00 am

Partnering in Neuroscience
Klaus MendlaGlobal Head, BD&L, CNS, Boehringer Ingelheim; Mark NuttallHead, Immunology & MS BD, Sanofi Genzyme; Cynthia Schwalm, EVP & President, North American Commercial Operations, Ipsen

11:00-11:30 am

Digital Advances and Disruptive Innovation in Neuroscience
Ana MaiquesCEO, Neuroelectrics; Eddie Martucci, Co-Founder & CEO, Akili Interactive; Dan Smith, Senior Director, Head of Translational Sciences, BlackThorn Therapeutics

11:30-12:00 pm

Advances in Neuromodulation, Neurostimulation, & Neurotrauma
Corey McCann, CEO, Pear Therapeutics; Lisa McKerracher, CEO, BioAxone bioSciences

12:00-1:00 pm

Networking Lunch

1:00-1:30 pm

Relapsing MS - Discovering and Developing the Possibilities

1:30-2:00 pm

Advances in Neurodegenerative and Neuromuscular Disorders
Jesús Martin-Garcia, CEO, GeNeuro SA

2:00-2:30 pm

Advances in Psychiatry
Michael DavidsonCMO, Minerva Neurosciences; Bob LinkePresident & CEO, Embera Neuro Therapeutics; Jason Uslaner, Executive Director, Symptomatics, Merck

2:30-2:50 pm

Genetics of Neurology & Psychiatry
Robert Gould, President & CEO, Fulcrum Therapeutics; Gerhard Koenig, CEO, Quartet Medicine

2:50-3:20 pm

Networking Break

3:20-3:40 pm

Fireside Chat

3:40-4:10 pm

Addressing Pain and Addiction
Danguole Altman
, Founder, Vapogenix; Mike Detke, CMO, Embera Neuro Therapeutics; Randall Stevens, CMO, Centrexion; Alex Tkachenko, CEO, Epiodyne
Moderator: Elliot Ehrich, EVP, R&D, Alkermes

4:10-4:40 pm

Advances in Neuroinflammation
Ole Isacson, Professor, HMS & NyaCell Therapeutics; Maurice ZaudererCEO, Vaccinex

4:40-5:10 pm

Advances in Parkinson's Disease
Jesse CedarbaumVP, Neurology Discovery & Development, Biogen; Ken RhodesCSO, Yumanity

4:50-6:00 pm

Cocktails and Hors d'oeuvres

Supporting Sponsors: (see all sponsors)

<